We are live on ! Find out more
SGAM

Smith Group Asset Management Portfolio holdings

AUM $2.46B
1-Year Est. Return 57.16%
This Fund
S&P 500
This Quarter Est. Return
+5.13%
1 Year Est. Return
+57.16%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$2.31B
AUM Growth
Cap. Flow
+$2.29B
Cap. Flow %
99.1%
Top 10 Hldgs %
20.5%
Holding
404
New
404
Increased
Reduced
Closed

Top Buys

Rank Stock Value
1
HD icon
Home Depot
HD
+$54.2M
2
BKNG icon
Booking.com
BKNG
+$51.5M
3
KR icon
Kroger
KR
+$50.8M
4
RMD icon
ResMed
RMD
+$50M
5
NTAP icon
NetApp
NTAP
+$48.2M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 17.08%
2 Technology 16.51%
3 Healthcare 14.6%
4 Financials 12.43%
5 Industrials 9.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VIRX
176
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$1.23M 0.05%
+1,134
New +$1.26M
OREX
177
DELISTED
Orexigen Therapeutics, Inc.
OREX
$1.21M 0.05%
+20,750
New +$1.28M
LXRX icon
178
Lexicon Pharmaceuticals
LXRX
$1.07B
$1.16M 0.05%
+76,494
New +$1.16M
AMWD
179
DELISTED
American Woodmark
AMWD
$1.08M 0.05%
+31,271
New +$1.07M
ROL icon
180
Rollins
ROL
$17.9B
$1.03M 0.04%
+133,650
New +$960K
ICUI icon
181
ICU Medical
ICUI
$4.56B
$999K 0.04%
+13,855
New +$916K
MACK
182
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$976K 0.04%
+18,411
New +$807K
MAGN
183
Magnera Corp
MAGN
$466M
$966K 0.04%
+2,961
New +$940K
DK icon
184
Delek US
DK
$3.72B
$916K 0.04%
+31,840
New +$1.12M
PGNX
185
DELISTED
Progenics Pharmaceuticals Inc
PGNX
$905K 0.04%
+202,820
New +$910K
KYTH
186
DELISTED
KYTHERA BIOPHARMACEUTICALS, INC COM
KYTH
$899K 0.04%
+33,220
New +$760K
ANN
187
DELISTED
ANN INC
ANN
$882K 0.04%
+26,573
New +$806K
COKE icon
188
Coca-Cola Consolidated
COKE
$12.4B
$869K 0.04%
+142,180
New +$867K
GEVA
189
DELISTED
SYNAGEVA BIOPHARMA CORP COM STK (DE)
GEVA
$862K 0.04%
+20,531
New +$936K
INCY icon
190
Incyte
INCY
$24.6B
$799K 0.03%
+36,315
New +$793K
NRCIB
191
DELISTED
National Research Corp Class B
NRCIB
$783K 0.03%
+22,406
New +$789K
EVR icon
192
Evercore
EVR
$11.5B
$763K 0.03%
+19,406
New +$752K
CECO icon
193
Ceco Environmental
CECO
$4.11B
$719K 0.03%
+58,473
New +$705K
AORT icon
194
Artivion
AORT
$1.28B
$704K 0.03%
+112,400
New +$686K
DPZ icon
195
Domino's
DPZ
$11.5B
$693K 0.03%
+11,910
New +$666K
ACHV icon
196
Achieve Life Sciences
ACHV
$685M
$648K 0.03%
+30
New +$671K
NAVG
197
DELISTED
Navigators Group Inc
NAVG
$643K 0.03%
+22,538
New +$657K
TOWR
198
DELISTED
Tower International, Inc.
TOWR
$642K 0.03%
+32,430
New +$567K
OZK icon
199
Bank OZK
OZK
$5.63B
$638K 0.03%
+29,458
New +$627K
PDLI
200
DELISTED
PDL BioPharma, Inc.
PDLI
$628K 0.03%
+81,327
New +$634K

Similar funds

Smith Group Asset Management's Q2 2013 Portfolio in Review

Q2 2013 is the first quarter with a 13F filing on record for Smith Group Asset Management, which disclosed 404 positions worth $2.31B. Its ten largest holdings account for 21% of the portfolio.

Its largest position is Home Depot: 720,749 shares worth $55.9M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 17% of assets, followed by Technology and Healthcare.

  • Smith Group Asset Management's largest Q2 2013 buy was Home Depot: 720,749 shares worth $55.9M.
  • Smith Group Asset Management's ten largest holdings make up 21% of its $2.31B portfolio in Q2 2013.
  • Smith Group Asset Management disclosed 404 positions in Q2 2013, its first 13F filing on record.

Based on Smith Group Asset Management's 13F filing for Q2 2013, filed 30 Jul 2013.